Immunological Impacts of VIP and PDL1 Double Knockout in Mice
1 of 4
Engineering Armored CAR T Cells to Secrete Functional VIPR Antagonist
2 of 4
Dynamic Immune and Stromal Modulation by Therapeutic Targeting of IL-6 in Pancreatic Cancer
3 of 4
A retrospective analysis of incidence trends, socio-demographic, and clinical characteristics in adolescents and young adults with pancreatic cancer in the United States using the SEER Database, 2004-2015